Publications

Detailed Information

Automating Rey Complex Figure Test scoring using a deep learning-based approach: a potential large-scale screening tool for cognitive decline

DC Field Value Language
dc.contributor.authorPark, Jun Young-
dc.contributor.authorSeo, Eun Hyun-
dc.contributor.authorYoon, Hyung-Jun-
dc.contributor.authorWon, Sungho-
dc.contributor.authorLee, Kun Ho-
dc.date.accessioned2023-09-14T05:24:58Z-
dc.date.available2023-09-14T14:25:31Z-
dc.date.issued2023-08-30-
dc.identifier.citationAlzheimer's Research & Therapy, Vol.15(1):145ko_KR
dc.identifier.issn1758-9193-
dc.identifier.urihttps://hdl.handle.net/10371/195545-
dc.description.abstractBackground
The Rey Complex Figure Test (RCFT) has been widely used to evaluate the neurocognitive functions in various clinical groups with a broad range of ages. However, despite its usefulness, the scoring method is as complex as the figure. Such a complicated scoring system can lead to the risk of reducing the extent of agreement among raters. Although several attempts have been made to use RCFT in clinical settings in a digitalized format, little attention has been given to develop direct automatic scoring that is comparable to experienced psychologists. Therefore, we aimed to develop an artificial intelligence (AI) scoring system for RCFT using a deep learning (DL) algorithm and confirmed its validity.

Methods
A total of 6680 subjects were enrolled in the Gwangju Alzheimers and Related Dementia cohort registry, Korea, from January 2015 to June 2021. We obtained 20,040 scanned images using three images per subject (copy, immediate recall, and delayed recall) and scores rated by 32 experienced psychologists. We trained the automated scoring system using the DenseNet architecture. To increase the model performance, we improved the quality of training data by re-examining some images with poor results (mean absolute error (MAE) ≥
5 [points]) and re-trained our model. Finally, we conducted an external validation with 150 images scored by five experienced psychologists.

Results
For fivefold cross-validation, our first model obtained MAE = 1.24 [points] and R-squared (R2
) = 0.977. However, after evaluating and updating the model, the performance of the final model was improved (MAE = 0.95 [points], R2
= 0.986). Predicted scores among cognitively normal, mild cognitive impairment, and dementia were significantly different. For the 150 independent test sets, the MAE and R2
between AI and average scores by five human experts were 0.64 [points] and 0.994, respectively.

Conclusion
We concluded that there was no fundamental difference between the rating scores of experienced psychologists and those of our AI scoring system. We expect that our AI psychologist will be able to contribute to screen the early stages of Alzheimers disease pathology in medical checkup centers or large-scale community-based research institutes in a faster and cost-effective way.
ko_KR
dc.description.sponsorshipThis research was supported by the Technology Innovation Program (20022810, Development and Demonstration of a Digital System for the evaluation of geriatric Cognitive impairment) funded By the Ministry of Trade, Industry & Energy(MOTIE, Korea), by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (NRF-2020R1F1A1052932), by the Healthcare AI Convergence Research & Development Program through the National IT Industry Promotion Agency of Korea (NIPA) funded by the Ministry of Science and ICT(No.1711120216), by the KBRI basic research program through the Korea Brain Research Institute funded by the Ministry of Science and ICT (22-BR-03–05), and by the Korea National Institute of Health research project (project No. 2021-ER1007-01).ko_KR
dc.language.isoenko_KR
dc.subjectAlzheimer’s disease-
dc.subjectRey Complex Figure Test-
dc.subjectScoring-
dc.subjectArtificial intelligence-
dc.subjectDeep learning-
dc.subjectConvolutional neural network-
dc.titleAutomating Rey Complex Figure Test scoring using a deep learning-based approach: a potential large-scale screening tool for cognitive declineko_KR
dc.typeArticleko_KR
dc.identifier.doi10.1186/s13195-023-01283-wko_KR
dc.citation.journaltitleAlzheimer's Research & Therapyko_KR
dc.language.rfc3066en-
dc.rights.holderBioMed Central Ltd., part of Springer Nature-
dc.date.updated2023-09-03T03:08:40Z-
dc.citation.volume15ko_KR
Appears in Collections:
Files in This Item:

Altmetrics

Item View & Download Count

  • mendeley

Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.

Share